Abstract:Oligomeric forms of alpha-synuclein are emerging as key mediators of pathogenesis in Parkinson's disease. Our understanding of the exact contribution of alpha-synuclein oligomers to disease is limited by the lack of a technique for their specific detection. We describe a novel method, the alpha-synuclein proximity ligation assay, which specifically recognizes alpha-synuclein oligomers. In a blinded study with post-mortem brain tissue from patients with Parkinson's disease (n = 8, age range 73-92 years, four males and four females) and age- and sex-matched controls (n = 8), we show that the alpha-synuclein proximity ligation assay reveals previously unrecognized pathology in the form of extensive diffuse deposition of alpha-synuclein oligomers. These oligomers are often localized, in the absence of Lewy bodies, to neuroanatomical regions mildly affected in Parkinson's disease. Diffuse alpha-synuclein proximity ligation assay signal is significantly more abundant in patients compared to controls in regions including the cingulate cortex (1.6-fold increase) and the reticular formation of the medulla (6.5-fold increase). In addition, the alpha-synuclein proximity ligation assay labels very early perikaryal aggregates in morphologically intact neurons that may precede the development of classical Parkinson's disease lesions, such as pale bodies or Lewy bodies. Furthermore, the alpha-synuclein proximity ligation assay preferentially detects early-stage, loosely compacted lesions such as pale bodies in patient tissue, whereas Lewy bodies, considered heavily compacted late lesions are only very exceptionally stained. The alpha-synuclein proximity ligation assay preferentially labels alpha-synuclein oligomers produced in vitro compared to monomers and fibrils, while stained oligomers in human brain display a distinct intermediate proteinase K resistance, suggesting the detection of a conformer that is different from both physiological, presynaptic alpha-synuclein (proteinase K-sensitive) and highly aggregated alpha-synuclein within Lewy bodies (proteinase K-resistant). These disease-associated conformers represent previously undetected Parkinson's disease pathology uncovered by the alpha-synuclein proximity ligation assay.

Single‐molecule two‐color coincidence detection of unlabeled alpha‐synuclein aggregates

Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution

Quantitative detection of α-Synuclein and Tau oligomers and other aggregates by digital single particle counting

Large-scale visualisation of α-synuclein oligomers in Parkinson’s disease brain tissue

Single Molecule Fluorescence Assay Of Alpha Synuclein Dimerization

Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain

Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain

Aptasensors for the Selective Detection of Alpha-Synuclein Oligomer by Colorimetry, Surface Plasmon Resonance and Electrochemical Impedance Spectroscopy

Identification of a Nanomolar Affinity Α-Synuclein Fibril Imaging Probe by Ultra-High Throughput in Silico Screening

Label-free Detection of Early Oligomerization of Α-Synuclein and Its Mutants A30P/E46K Through Solid-State Nanopores.

Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease

Binding-Triggered Hybridization Chain Reaction Cascade Muti-site Activated CRISPR/Cas12a Signal Amplification Strategy for Sensitive Detection of α-Synuclein

Machine Learning-Assisted Fluorescence/fluorescence Colorimetric Sensor Array for Discriminating Amyloid Fibrils

An α-helical peptide-based plasmonic biosensor for highly specific detection of α-synuclein-toxic oligomers

Specific Detection of Endogenous S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay

Conformational equilibria in monomeric alpha-synuclein at the single molecule level

Single molecule fingerprinting reveals different growth mechanisms in seed amplification assays for different polymorphs of αSynuclein fibrils

The combination of optogenetic-induced protein aggregation and proximity biotinylation assays strongly implicates endolysosomal proteins in the early stages of α-synuclein aggregation

Detecting Morphologically Distinct Oligomeric Forms of Α-Synuclein*

Promising Molecular Architectures for Two-Photon Probes in the Diagnosis of α-Synuclein Aggregates

Intrinsic and Membrane-Facilitated Α-Synuclein Oligomerization Revealed by Label-Free Detection Through Solid-State Nanopores